© Reuters. OKYO Pharma (OKYO) IPO Opens 13% Higher
Today’s IPO for OKYO Pharma Limited (Nasdaq: OKYO) opened for trading at $4.50 per ADS after pricing 625,000 ADSs (representing 40,625,000 new ordinary shares of no par value) at a price of $4.00 per ADS.
ThinkEquity LLC was the sole bookrunning manager for the IPO.
OKYO Pharma is a life sciences company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain.
Be the first to comment